In summary, we identified five key genes (SFN, ARHGAP9, VSIG4, ISG20, CD3G) that can distinguish patients with renal fibrosis from controls, making them potential biomarkers for disease diagnosis and treatment monitoring. This evidence concerns the gene ARHGAP9 and renal fibrosis.